Transformed Indolent Lymphoma

• CLINICAL_TRIALS trial_result · 2019-04-23
  Clinical Trial Update: Study of Ibrutinib in Combination With Bendamustine and Rituximab for Patients With Relapsed/Refractory Aggressive BCL [Phase 2]

  Phase 2 trial evaluating ibrutinib with bendamustine and rituximab for relapsed/refractory aggressive B-cell lymphomas, with several DLBCL-r…

• CLINICAL_TRIALS withdrawal · 2016-11-25
  Clinical Trial Update: Efficacy and Safety Study of MDV9300 in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) [Phase 2]

  This clinical trial update states that the Phase 2 study of MDV9300 in relapsed or refractory diffuse large B-cell lymphoma has been withdra…